)
Jazz Pharmaceuticals (JAZZ) investor relations material
Jazz Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
The annual general meeting (AGM) is scheduled for July 23, 2026, with several key proposals up for shareholder vote.
Shareholders of record as of May 28, 2026, are eligible to vote at the AGM.
Employees who are also shareholders are encouraged to participate in the voting process to ensure their shares are represented.
Voting matters and shareholder proposals
The board and management recommend voting "FOR" all director nominees and the other five proposals presented at the AGM.
Voting instructions were distributed via mail or electronically, with specific guidance for those using E*Trade services.
Board of directors and corporate governance
The board has nominated directors for election at the AGM and supports their approval.
- Strong neuroscience growth and robust pipeline progress offset oncology headwinds, supporting 2024 outlook.JAZZ
Bank of America 2025 Healthcare Conference9 Jul 2026 - Q1 2025 revenue steady at $898M; Chimerix closed; 2025 outlook affirmed despite headwinds.JAZZ
Q1 20259 Jul 2026 - Record Q3 2025 revenue, raised EPS guidance, and key FDA approvals drive future growth.JAZZ
Q3 20259 Jul 2026 - Record 2025 revenue of $4.3B and robust rare disease growth set up double-digit gains for 2026.JAZZ
Q4 20259 Jul 2026 - Lurbinectedin plus atezolizumab significantly improves survival in first-line ES-SCLC maintenance.JAZZ
Status Update9 Jul 2026 - Robust oncology advances and sleep portfolio growth drive confidence in future performance.JAZZ
Jefferies Global Healthcare Conference8 Jul 2026 - FDA-approved Ziihera delivers strong efficacy and safety for HER2-positive BTC, with broad expansion plans.JAZZ
Status Update8 Jul 2026 - Q3 2024 revenue up 9% to $1.05B, net income up 46%, and EPS outlook raised.JAZZ
Q3 20248 Jul 2026 - 2024 revenue hit $4.1B (+6% YoY); 2025 guidance targets 5% growth, led by Xywav and Epidiolex.JAZZ
Q4 20248 Jul 2026
Next Jazz Pharmaceuticals earnings date
Next Jazz Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)